Abstract
A critical review of the literature reveals that different types of thyroid carcinomas have been interpreted as poorly differentiated, including the tall and columnar cell variants as well as carcinomas with insular, trabecular, and solid growth patterns. In some publications the growth patterns have been emphasized, while in others histologic patterns and cytologic features are considered important for identification. However, insular, trabecular, nodular, and solid growth patterns lack specificity because they can be observed in hyperplastic lesions and benign thyroid tumors. The cytologic features of the vast majority of poorly differentiated thyroid carcinomas are similar to or overlap with those of papillary or follicular carcinomas. Cytologic atypia, mitotic activity, and necrosis—believed by some investigators to be useful clues in the diagnosis of poorly differentiated carcinomas—do not reflect cell differentiation, especially in endocrine organs. It is therefore not surprising that the immunohistochemical profile and the molecular abnormalities described in this heterogeneous group of carcinomas lack specificity and are not useful diagnostic tools. Because poorly differentiated thyroid carcinomas have not been well defined, currently it is not possible to set the threshold between well-differentiated and poorly differentiated thyroid carcinomas with follicular phenotype. The authors believe that the vast majority of poorly differentiated thyroid carcinomas are in fact examples of papillary or follicular carcinomas with unusual growth patterns.
Similar content being viewed by others
References
Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855, 1983.
Hawk WA, Harzard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 43:207–216, 1976.
Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: A reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol 20:964–974, 1996.
Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde struma”. Am J Surg Pathol 8:655–668, 1984.
Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Surg Pathol 85:77–80, 1986.
Sobrinho-Simoes M, Nesland J, Johannessen J. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 89:264–267, 1988.
Wening BM, Thompson LD, Adair CF, et al. Thyroid papillary carcinoma of columnar cell type: clinicopathologic study of 16 cases. Cancer 82:740–753, 1998.
Papotti M, Micca B, Favero A, et al. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17:291–301, 1993.
Vardaman JC, Albores-Saavedra J. Cytoplasmic inclusions in thyroid neoplasms of follicular cell origin (abstract). Am J Clin Pathol 96:410, 1991.
Ashfaq R, Vuitch F, Delgado R, Albores-Saavedra J. Papillary and follicular thyroid carcinomas with an insular component. Cancer 73:416–423, 1994.
Sasaki A, Daa T, Kashima T, et al. Insular components as a risk factor of thyroid carcinoma. Pathol Int 46:939–946, 1996.
Nishida T, Katayama S, Tsujimoto M, et al. Clinicopathologic significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23:205–211, 1999.
Albores-Saavedra J, Housini I, Vuitch F, et al. Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer 80:1110–1116, 1997.
Albores-Saavedra J, Sharma S. Poorly differentiated follicular thyroid carcinoma with rhabdoid phenotype: a clinicopathologic, immunohistochemical and electron microscopic study of two cases. Mod Pathol 14:98–104, 2001.
Ghossein RA, Rosai J, Heffess C. Dyshormonogenetic goiter: a clinicopathologic study of 56 cases. Clin Res 8:238–292, 1997.
Carney JA, Ryan J, Gollmen RR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591, 1987.
Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. In: Atlas of tumor pathology. Series 3. Fascicle 5. Washington, DC: AFIP, 1992.
Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathol 25:549–556, 1994.
Perrier ND, Van Heerden JA, Goellner JR, et al. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg 22:738–743, 1998.
Wreesmann VB, Ghossein RA, Patel SG, et al. Genome wide appraisal of thyroid cancer progression. Am J Pathol 161:1549–1556, 2002.
Akslen LA, Li Volsi VA. Poorly differentiated thyroid carcinoma—it is important (letter). Am J Surg Pathol 24:310–313, 2000.
Jorda M, Gonzalez-Campora, R, Mora J, et al. Prognostic factors in follicular carcinoma of the thyroid. Arch Pathol Lab Med 117:631–635, 1993.
Thompson LDR, Wieneke JA, Paal E, et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91:505–524, 2001.
Schmid KW, Tötsch M, Öfner D, et al. Minimally invasive follicular thyroid carcinoma: a clinicopathologic study. Curr Topics Pathol 91:37–43, 1997.
Raphael SJ. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocrine Pathol 13:301–311, 2002.
Wiseman SM, Loree TR, Hicks WL, et al. Anaplastic thyroid cancer evolved from papillary carcinoma. Arch Otolaryngol Head Neck Surg 129:96–100, 2003.
Takeuchi Y, Daa T, Kashima K, et al. Mutation of p53 in thyroid carcinoma with an insular component. Thyroid 9:377–381, 1999.
Park KY, Koh JM, Kim YI, et al. Prevalences of G, α ras, p53 mutations and ret/PTC rear-rangements in differentiated thyroid tumors in Korean population. Clin Endocrinol 49:317–323, 1998.
Fogelfeld L, Bauer TK, Schneider AB, et al. p53 gene mutations in radiation-induced thyroid cancer. J Clin Endocrinol Metab 81:3039–3044, 1996.
Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinoma and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399–5404, 2003.
Santoro M, Papotti M, Chiappetta G, et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 87:370–379, 2002.
Owens LV, Xu L, Yang X, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 3:100–105, 1996.
Gubiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357, 1996.
Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79:804–812, 1997.
Hundahl SA, Fleming ID, Gremgen AM, et al. Two hundred eighty-six cases of parathyroid carcinoma treated in the US between 1985–1995. Cancer 86:538–544, 1999.
Weiss LM, Madeiros LJ, Vickery AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202–206, 1989.
Solcia E, Capella C, Klöppel G. Tumors of the pancreas. In: Atlas of tumor pathology. Fascicle 20. Third series. Washington DC: AFIP, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albores-Saavedra, J., Carrick, K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 15, 297–305 (2004). https://doi.org/10.1385/EP:15:4:297
Issue Date:
DOI: https://doi.org/10.1385/EP:15:4:297